DUBLIN--(BUSINESS WIRE)--Malin Corporation plc. (“Malin”), an Irish-based global life sciences company, today announces it has invested $80 million in Immunocore Limited (“Immunocore”), a world-leading biotechnology company developing novel T cell receptor (TCR) based therapies with the potential to treat a variety of cancers, viral infections and autoimmune diseases. Malin will join Woodford Investment Management, Eli Lilly and Company, RTW Funds as well as a number of existing investors in Im